Concepedia

Danny Galdermans

DG

Statistics

Publications

6

Citations

337

H-Index

6

Active since

1996

Affiliations

ZNA Middelheim Hospital(Current)

Danny Galdermans is an author at ZNA Middelheim Hospital specializing in oncology, radiation oncology, and medicine.

Top concepts

Publications per year

1996–2016

6

Publications

6

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 131 citations · Full text

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

Jan P. van Meerbeeck, C. Debruyne, Nico van Zandwijk et al. · British Journal of Cancer · 1996 · 85 citations · Full text

, , +6

Small Cell Lung Carcinoma Presenting as Collapsin Response-Mediating Protein (CRMP) -5 Paraneoplastic Optic Neuropathy

Rishi Sheorajpanday, Hans Slabbynck, W. Van De Sompel et al. · Journal of Neuro-Ophthalmology · 2006 · 46 citations

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

Jan P. van Meerbeeck, Paul Baas, C. Debruyne et al. · European Journal of Cancer · 2002 · 34 citations

, , +3

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

Jacques De Grève, Jan P. van Meerbeeck, Johan Vansteenkiste et al. · PLoS ONE · 2016 · 21 citations · Full text

1–5 of 6